Actively Recruiting
Feminizing Treatment in Transgender Women and Non-binary Persons
Led by Odense University Hospital · Updated on 2025-03-21
100
Participants Needed
1
Research Sites
708 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
CONDITIONS
Official Title
Feminizing Treatment in Transgender Women and Non-binary Persons
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Assigned male at birth and eligible for gender affirming feminizing treatment
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
OdenseUH
Odense, Denmark, 5230
Actively Recruiting
Research Team
D
Dorte Glintborg
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here